Title |
Cognitive effects of a dietary supplement made from extract of Bacopa monnieri, astaxanthin, phosphatidylserine, and vitamin E in subjects with mild cognitive impairment: a noncomparative, exploratory clinical study
|
---|---|
Published in |
Neuropsychiatric Disease and Treatment, February 2014
|
DOI | 10.2147/ndt.s51092 |
Pubmed ID | |
Authors |
Danilo Zanotta, Silvana Puricelli, Guido Bonoldi |
Abstract |
A prospective cohort, noncomparative, multicenter trial was conducted to explore the potential of a phytotherapeutic compound, available as a dietary supplement and containing extracts of Bacopa monnieri and Haematococcus pluvialis (astaxanthin) plus phosphatidylserine and vitamin E, in improving cognition in subjects diagnosed with mild cognitive impairment. Enrolled subjects (n=104) were aged 71.2±9.9 years and had a mini-mental state examination score of 26.0±2.0 (mean ± standard deviation). They underwent the Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog) test and the clock drawing test at baseline and upon completion of a 60-day period of dietary supplementation with one tablet daily of the tested compound. In 102 assessable subjects, total ADAS-cog scores improved from 13.7±5.8 at baseline to 9.7±4.9 on day 60, and the clock drawing test scores improved from 8.5±2.3 to 9.1±1.9. Both changes were statistically significant (P<0.001). Memory tasks were the individual components of ADAS-cog showing the largest improvements. In a multivariate analysis, larger improvements in total ADAS-cog score were associated with less compromised baseline mini-mental state examination scores. Perceived efficacy was rated as excellent or good by 62% of study subjects. The tested compound was well tolerated; one nonserious adverse event was reported in the overall study population, and perceived tolerability was rated excellent or good by 99% of the subjects. In conclusion, dietary supplementation with the tested compound shows potential for counteracting cognitive impairment in subjects with mild cognitive impairment and warrants further investigation in adequately controlled, longer-term studies. |
Twitter Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | <1% |
India | 1 | <1% |
Netherlands | 1 | <1% |
United States | 1 | <1% |
Unknown | 111 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 24 | 21% |
Student > Bachelor | 20 | 17% |
Student > Master | 14 | 12% |
Student > Ph. D. Student | 11 | 10% |
Other | 10 | 9% |
Other | 14 | 12% |
Unknown | 22 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 28 | 24% |
Agricultural and Biological Sciences | 17 | 15% |
Psychology | 10 | 9% |
Neuroscience | 7 | 6% |
Biochemistry, Genetics and Molecular Biology | 6 | 5% |
Other | 21 | 18% |
Unknown | 26 | 23% |